Inflammation, Brain Health, and Mental Well-Being: What We Actually Know

Inflammation has become one of the most frequently used explanations in modern wellness medicine. Fatigue is blamed on inflammation. Brain fog is blamed on inflammation. Depression, weight gain, poor sleep, joint pain, hormonal symptoms, and cognitive decline may all eventually be described as inflammatory problems.

There is enough legitimate science behind inflammation to make that language sound convincing. There is also enough uncertainty that the word can easily become a substitute for diagnosis.

Dr. Kathryn Retzler's clinical approach is more restrained. Inflammation is relevant because immune signaling intersects with vascular health, glucose regulation, adipose tissue, sleep, hormones, gastrointestinal physiology, and the central nervous system. It is rarely useful to decide in advance that inflammation is the explanation for a patient's symptoms and then work backward to prove it.

The better clinical work is to understand what is actually happening in the patient.

For the larger framework, see The HormoneSynergy® Longevity Medicine Model.

Inflammation Is Normal Biology

Inflammation is not inherently pathological. Acute inflammatory responses are essential to immunity, tissue repair, and recovery from injury. Problems arise when inflammatory pathways remain activated because of ongoing disease or physiologic stress, or when immune regulation itself becomes abnormal.

The term chronic low-grade inflammation is commonly used in metabolic medicine to describe persistent elevations in inflammatory signaling associated with obesity, particularly visceral adiposity, insulin resistance, aging, smoking, sleep disruption, and several chronic diseases.

That state is different from the intense inflammatory response produced by an acute bacterial infection or active autoimmune disease. It is also not something a patient can reliably identify from symptoms alone.

This distinction is important because “reducing inflammation” is not a diagnosis or a complete treatment plan. If inflammation is being driven by untreated sleep apnea, periodontal disease, rheumatoid arthritis, smoking, visceral obesity, or poorly controlled diabetes, the clinical priority is the underlying condition.

How the Body Communicates With the Brain

The brain is not immunologically isolated from the rest of the body. Peripheral immune activity can influence the central nervous system through several routes, including circulating cytokines, endothelial and blood-brain barrier signaling, autonomic and vagal pathways, immune-cell activity, and metabolic signals.

Within the central nervous system, microglia and astrocytes participate in immune surveillance and inflammatory responses. These cells have normal physiologic functions and should not simply be regarded as evidence of disease whenever they become activated.

Researchers are increasingly interested in how persistent systemic metabolic inflammation may alter communication at the blood-brain barrier, meninges, hypothalamus, and other brain regions. Obesity provides one of the better studied examples because adipose tissue itself is metabolically and immunologically active.

A 2024 review in Nature Metabolism describes how obesity-associated inflammation can disrupt communication between peripheral tissues and the brain through immune, vascular, nutrient, and neural pathways.

See Obesity-Induced Inflammation: Connecting the Periphery to the Brain.

Depression and Inflammation: A Real Association, but Not One Disease

Inflammation and depression are connected in a subset of patients. Meta-analytic research has identified differences in inflammatory cytokines, including IL-6 and TNF-alpha, among some people with major depressive disorder compared with people without depression.

That does not make major depression an inflammatory disease in the same way that rheumatoid arthritis is an inflammatory disease.

Depression is heterogeneous. Genetics, life experience, trauma, social conditions, sleep, medical illness, medications, endocrine disorders, substance use, neurobiology, and numerous other factors can contribute. Some patients appear to have a more prominent inflammatory phenotype than others.

This difference may eventually become clinically important. A 2026 meta-analysis examined randomized trials of anti-inflammatory treatments specifically in depressed patients with evidence of elevated inflammation. Depressive symptoms and anhedonia improved modestly on average, although treatment response and remission rates were not significantly different. The findings are interesting because they support the possibility that inflammatory phenotype may eventually help identify subgroups of patients rather than implying that anti-inflammatory therapy should be used routinely for depression.

See Anti-Inflammatory Treatment in Depression With Elevated Inflammation.

Depression deserves appropriate mental-health care. An elevated inflammatory marker should add clinical context, not replace psychiatric diagnosis or treatment.

For our broader discussion, see Depression, Inflammation, and Longevity.

What About Brain Fog?

“Brain fog” is a useful description of an experience, but it is not a medical diagnosis. Patients may use the term for slowed thinking, impaired concentration, word-finding difficulty, forgetfulness, mental fatigue, or simply not feeling cognitively sharp.

Inflammatory illness can produce cognitive symptoms. Anyone who has had influenza understands that systemic immune activation can temporarily change energy, motivation, concentration, and cognition.

Persistent symptoms require a broader differential diagnosis. Sleep deprivation and obstructive sleep apnea, thyroid dysfunction, anemia, B12 deficiency, medication effects, depression, anxiety, menopause, substance use, metabolic disease, post-infectious illness, neurologic disease, and inadequate nutrition can all present with complaints that patients describe as brain fog.

Calling these symptoms “neuroinflammation” before establishing what is causing them can send the evaluation in the wrong direction.

Inflammation and Cognitive Aging

The relationship between inflammation and cognitive aging is also biologically plausible and supported by substantial observational and mechanistic research. Chronic vascular disease, metabolic dysfunction, obesity, insulin resistance, and inflammatory signaling often travel together, and each may influence long-term brain health.

This makes causality difficult to untangle. A person with visceral obesity may simultaneously have hypertension, dyslipidemia, insulin resistance, sleep apnea, reduced physical activity, systemic inflammation, and vascular disease. It would be difficult to attribute later cognitive decline to one inflammatory pathway while ignoring the rest of that physiology.

Prospective studies have nevertheless found associations between inflammatory dietary patterns and later cognitive impairment, while experimental and translational research continues to examine microglial activation, blood-brain barrier changes, vascular injury, and metabolic signaling.

For a more focused discussion, see Inflammation and Cognitive Aging.

Metabolic Health Is Part of Brain Health

One of the strongest reasons to include inflammation in a longevity-medicine discussion of the brain is its relationship with metabolic disease.

Insulin resistance, visceral adiposity, dyslipidemia, hypertension, and type 2 diabetes are not confined to glucose or cardiovascular medicine. They are also relevant to cerebral vascular health and cognitive aging.

Adipose tissue, particularly dysfunctional visceral adipose tissue, releases adipokines and inflammatory mediators. Insulin resistance alters metabolic signaling. Hypertension and atherogenic lipoproteins affect cerebral vasculature. Sleep apnea, which is common in metabolic disease, introduces intermittent hypoxia and additional cardiovascular and cognitive stress.

Inflammation is therefore one part of a larger metabolic environment rather than a competing explanation.

Related HormoneSynergy® resources include:

• Insulin Resistance and Mental Health
• Fasting Insulin and Metabolic Health
• HOMA-IR and Insulin Resistance

Sleep Changes Both Brain Function and Inflammatory Signaling

Poor sleep can change how a person thinks and feels long before a laboratory test becomes abnormal. Attention, memory, emotional regulation, appetite, glucose regulation, blood pressure, and daytime energy are all influenced by sleep.

Sleep also interacts with immune physiology. A 2025 meta-analysis of controlled sleep-deprivation studies found that several consecutive nights of partial sleep restriction were associated with increases in circulating IL-6 and CRP. A single poor night did not consistently produce the same effect.

That distinction is clinically useful. It supports the relationship between persistent sleep loss and inflammatory physiology without turning every episode of insomnia into an inflammatory disease.

See Effects of Experimental Sleep Deprivation on Peripheral Inflammation.

Sleep evaluation becomes particularly important when cognitive or mood symptoms coexist with snoring, witnessed apnea, morning headaches, daytime sleepiness, resistant hypertension, atrial fibrillation, or other features suggesting obstructive sleep apnea.

• Sleep, Mental Health, and Longevity
• Sleep and Hormone Changes

Where Hormones Fit

Hormonal transitions can affect mood, sleep, energy, cognition, body composition, and metabolic health. Those overlapping symptoms sometimes lead patients to assume that hormones are either causing inflammation or that inflammation is creating a hormone imbalance.

The physiology is more complicated.

Estradiol, testosterone, thyroid hormones, cortisol, insulin, and other endocrine signals interact with immune and metabolic pathways, but a nonspecific symptom such as fatigue or poor concentration cannot tell us which pathway is responsible.

Perimenopause illustrates the problem well. A woman may simultaneously experience vasomotor symptoms, fragmented sleep, mood changes, altered body composition, and subjective cognitive symptoms. Treating appropriate menopausal symptoms may improve how she feels without proving that inflammation caused the symptoms in the first place.

Likewise, thyroid disease can produce mood and cognitive symptoms and should be diagnosed and treated as thyroid disease rather than folded into a generic inflammatory explanation.

• Hormones and Mental Health
• Testosterone and Mood
• Thyroid and Mental Health

Can We Measure Inflammation?

Yes, but laboratory testing has limits.

C-reactive protein is produced by the liver in response to inflammatory signaling. High-sensitivity CRP, or hsCRP, can detect relatively low concentrations and is well established as a cardiovascular risk marker when interpreted in the appropriate clinical setting.

What hsCRP cannot do is tell us where inflammation is occurring. An elevated value can accompany infection, obesity, autoimmune disease, tissue injury, smoking, periodontal disease, and numerous other conditions.

hsCRP is not a blood test for neuroinflammation.

The same caution applies to cytokine panels. Measuring IL-6, TNF-alpha, or other immune mediators in peripheral blood may be useful in research and selected clinical circumstances, but these tests have not become routine diagnostic tools for determining whether depression, anxiety, brain fog, or memory complaints are being caused by inflammation in the brain.

Laboratory data are most useful when they answer a defined clinical question rather than when a large panel is ordered in search of an explanation for nonspecific symptoms.

What We Can Actually Do About Chronic Inflammatory Risk

Much of the useful work is remarkably unexotic.

Smoking cessation reduces inflammatory and cardiovascular risk. Regular physical activity improves insulin sensitivity, vascular function, body composition, mood, and brain health. Resistance training helps preserve muscle and glucose disposal. A Mediterranean-style eating pattern rich in vegetables, legumes, fruit, nuts, seeds, fish, olive oil, and minimally processed foods addresses cardiovascular and metabolic risk without requiring an “anti-inflammatory detox.”

Adequate sleep matters. Treating obstructive sleep apnea matters. Visceral adiposity and insulin resistance deserve treatment when present. Blood pressure and ApoB-mediated cardiovascular risk deserve attention. Periodontal disease, inflammatory disease, and chronic infection should be evaluated and treated rather than covered with supplements marketed for inflammation.

Medication may also be appropriate depending on the condition. Statins, antihypertensive medications, diabetes therapies, antidepressants, hormone therapy, anti-inflammatory medications, and other interventions should be used according to the clinical problem they are designed to treat rather than divided into “natural” and “medical” camps.

There is no virtue in lowering an inflammatory marker while leaving the disease producing it untreated.

What About Anti-Inflammatory Supplements?

Omega-3 fatty acids, curcumin, specialized pro-resolving mediators, and numerous other nutritional compounds are frequently discussed in this context. Some have meaningful human research, while others are supported primarily by mechanistic or early clinical data.

They may have a role in selected patients. They should not be represented as treatments for “brain inflammation” simply because laboratory experiments show effects on inflammatory pathways.

The same principle applies throughout longevity medicine: the intervention should have a clinical reason, an appropriate dose, a reasonable evidence base, a safety review, and some way of deciding whether continued use makes sense.

The HormoneSynergy® Approach

At HormoneSynergy®, we do not assume that inflammation is the explanation for every symptom associated with aging. We also do not ignore the substantial evidence connecting immune activity with metabolic disease, cardiovascular disease, sleep, mood, and brain physiology.

A patient presenting with fatigue, low mood, poor concentration, or memory concerns may need evaluation of sleep, cardiovascular risk, medications, thyroid function, metabolic health, nutritional status, hormones when clinically relevant, depression or anxiety, neurologic symptoms, substance use, and other medical conditions.

Inflammatory markers can contribute to that evaluation when they answer a useful clinical question. They do not replace it.

This approach reflects both our Mental Health and Longevity Medicine framework and the broader HormoneSynergy® Longevity Medicine Model.

The clinical objective is not to make every symptom inflammatory. It is to understand the physiology well enough to treat what is actually there.

Related HormoneSynergy® Resources

• Mental Health and Longevity Medicine
• Inflammation and Cognitive Aging
• Depression, Inflammation, and Longevity
• Insulin Resistance and Mental Health
• Sleep, Mental Health, and Longevity
• Hormones and Mental Health
• Inflammation and Longevity Medicine

Frequently Asked Questions

Can inflammation affect the brain?

Yes. Peripheral immune and inflammatory signals can communicate with the central nervous system through vascular, metabolic, immune, and neural pathways. This biology is well established, although it does not mean that every cognitive or psychiatric symptom is caused by inflammation.

Does inflammation cause depression?

Inflammatory abnormalities are present in a subset of people with major depression, and inflammation may contribute to symptoms in some patients. Depression is nevertheless a heterogeneous disorder with many biological, psychological, medical, and social contributors. Inflammation should not be treated as a universal explanation.

Can a CRP test tell whether my brain is inflamed?

No. CRP and hsCRP measure peripheral inflammatory activity and are not direct tests of neuroinflammation. An elevated result can have many causes and should be interpreted within the person's broader medical context.

Can poor sleep increase inflammation?

Persistent sleep restriction can influence inflammatory signaling. Controlled human studies suggest that several consecutive nights of partial sleep deprivation can increase circulating markers such as IL-6 and CRP. Sleep also affects cognition, mood, glucose regulation, blood pressure, and cardiovascular health independently of inflammation.

Does insulin resistance affect brain health?

Insulin resistance commonly occurs alongside visceral adiposity, hypertension, dyslipidemia, vascular disease, and chronic low-grade inflammation. These overlapping metabolic and vascular factors are increasingly recognized as relevant to long-term cognitive and brain health.

Should depression be treated with anti-inflammatory medication?

Not routinely. Research suggests that selected patients with depression and elevated inflammatory markers may represent a subgroup worth further study, but anti-inflammatory treatment has not replaced established psychiatric care. Treatment should be individualized with an appropriately qualified clinician.

Can supplements lower neuroinflammation?

Some nutrients and botanical compounds influence inflammatory pathways, but demonstrating an effect on a laboratory pathway is not the same as proving treatment of neuroinflammation or improvement in meaningful neurologic outcomes. Supplements should be considered according to the specific indication and evidence.

Selected Clinical References

Obesity-Induced Inflammation: Connecting the Periphery to the Brain — Nature Metabolism, 2024

Anti-Inflammatory Treatment for Depression With Elevated Inflammation — American Journal of Psychiatry, 2026

Cytokine Levels in First-Episode and Antidepressant-Naïve Major Depression — Systematic Review and Meta-Analysis, 2025

Effects of Experimental Sleep Deprivation on Peripheral Inflammation — Meta-Analysis, 2025

Dietary Inflammatory Potential and Risk of Cognitive Impairment — Prospective-Cohort Meta-Analysis, 2024

Editorial Transparency

This article was developed with AI-assisted drafting support and reviewed and edited by the HormoneSynergy® team for clinical accuracy, clarity, and relevance. It reflects the educational perspective of HormoneSynergy® and is not a substitute for individualized medical, neurologic, or mental-health evaluation and treatment.